Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Silke Lutz has worked on the following 1 EPO patent applications which have been published in the last five years:

EP11715329

USES OF DGAT1 INHIBITORS

IPC classification:
A61K 31/42
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature